• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
• 3. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 4. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 5. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053

Recent Advances in the Application of 4-Chlorobenzene-1,3-disulfonyl Dichloride (CAS: 2891-17-0) in Chemical Biology and Pharmaceutical Research

4-Chlorobenzene-1,3-disulfonyl dichloride (CAS: 2891-17-0) has emerged as a key synthetic intermediate in pharmaceutical and chemical biology research due to its versatile reactivity as a sulfonylating agent. Recent studies have demonstrated its expanding applications in drug discovery, particularly in the development of sulfonamide-based therapeutics and functional materials. This research brief synthesizes the latest findings from 2022-2023 literature regarding the compound's novel applications and synthetic utility.

A significant breakthrough published in the Journal of Medicinal Chemistry (2023) demonstrated the compound's effectiveness in creating sulfonamide-based kinase inhibitors. Researchers utilized 2891-17-0 as a precursor to develop selective JAK3 inhibitors with improved pharmacokinetic profiles. The disulfonyl chloride moiety allowed for efficient parallel synthesis of diverse sulfonamide derivatives, enabling rapid structure-activity relationship studies. This approach yielded compounds with nanomolar potency and >100-fold selectivity over other JAK isoforms.

In materials science applications, a 2022 study in ACS Applied Materials & Interfaces reported innovative uses of 4-chlorobenzene-1,3-disulfonyl dichloride for creating self-assembled monolayers (SAMs) on gold surfaces. The compound's dual reactive sites enabled the formation of highly ordered, cross-linked molecular architectures with potential applications in biosensor development. Surface characterization techniques including XPS and AFM confirmed the formation of uniform monolayers with excellent stability under physiological conditions.

Recent synthetic methodology developments have expanded the utility of 2891-17-0 in click chemistry applications. A Nature Communications (2023) publication described its use as a bifunctional linker for constructing sulfonamide-based PROTACs (proteolysis-targeting chimeras). The researchers developed a modular synthetic platform where the dichloride serves as a central scaffold for connecting E3 ligase ligands to target protein binders, demonstrating successful degradation of several challenging oncology targets.

From a safety and handling perspective, new studies have provided updated toxicological data for this compound. Research in Chemical Research in Toxicology (2022) characterized its reactivity with biological nucleophiles, identifying glutathione as the primary detoxification pathway. These findings have important implications for industrial handling procedures and the design of safer derivatives for pharmaceutical applications.

The commercial availability and synthetic versatility of 4-chlorobenzene-1,3-disulfonyl dichloride continue to drive innovation across multiple research areas. Current patent analyses (2023) show increasing filings for its use in covalent inhibitor development, particularly for targeting cysteine residues in challenging drug targets. As synthetic methodologies advance, this compound is positioned to play an even greater role in the development of next-generation therapeutics and functional materials.

• 98-60-2(4-Chlorobenzene-1-sulfonyl chloride)
• 2905-23-9(2-Chlorobenzenesulfonyl chloride)
• 51527-73-2(2,4,6-trichlorobenzene-1-sulfonyl chloride)
• 2888-06-4(3-Chlorobenzenesulfonyl chloride)
• 82417-45-6(2,3-dichlorobenzene-1-sulfonyl chloride)
• 6579-54-0(2,6-dichlorobenzene-1-sulfonyl chloride)
• 15945-07-0(2,4,5-Trichloro-benzenesulfonyl chloride)
• 16271-33-3(2,4-Dichlorobenzenesulfonyl chloride)
• 34732-09-7(2,3,4-Trichlorobenzenesulfonyl chloride)
• 5402-73-3(2,5-Dichlorobenzenesulfonyl chloride)